Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs Vir Biotechnology, Inc. (VIR)

Lakefront Biotherapeutics - Sponsored ADR and Vir Biotechnology, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Vir Biotechnology, Inc. are of similar size ($2.3B and $2.2B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against −52.2%. Lakefront Biotherapeutics - Sponsored ADR has the higher net margin (−6.81% vs −61.0%) and the higher return on invested capital (0.00% vs −30.3%). Across the 18 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 12 and Vir Biotechnology, Inc. on 6.

Valuation

Metric LKFT VIR Biotechnology median
P/E n/m n/m 11.58
P/S 7.79 7.33 9.61
P/B 0.58 2.48 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.96 n/m 0.72
EV/Sales (1.42) 5.81 9.43
Earnings yield (0.85%) (9.52%) (32.28%)
Free cash flow yield (27.15%) (6.39%) (22.27%)

Profitability

Metric LKFT VIR Biotechnology median
Gross margin 89.75% 99.99% 68.81%
Operating margin (90.11%) (69.82%) 0.00%
Net margin (6.81%) (61.03%) 0.00%
Free cash flow margin 0.00% (46.87%) 0.00%
Return on equity 0.00% (21.84%) (50.30%)
Return on assets 0.00% (17.34%) (45.47%)
Return on invested capital 0.00% (30.32%) 0.00%

Growth

Metric LKFT VIR Biotechnology median
Revenue growth (TTM) (52.22%) 1,695.96% 6.78%
EPS growth (last fiscal year) 355.37% 17.49% 29.88%
Revenue growth, 5-year CAGR 15.75% (2.14%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LKFT VIR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 32.84 6.30 4.74
Net debt to EBITDA (8.53) 1.02 1.01

Dividend

Metric LKFT VIR Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric LKFT VIR Biotechnology median
Market cap 2.19b 2.25b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack